Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Nov;35(11):2807–2809. doi: 10.1128/jcm.35.11.2807-2809.1997

Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995.

K Hawrami 1, I J Hart 1, F Pereira 1, S Argent 1, B Bannister 1, B Bovill 1, D Carrington 1, M Ogilvie 1, S Rawstorne 1, Y Tryhorn 1, J Breuer 1
PMCID: PMC230066  PMID: 9350738

Abstract

The molecular epidemiology of varicella-zoster virus in London, England, between 1971 and 1995 was examined by using two informative polymorphic markers, variable repeat region R5 and a BglI restriction site in gene 54. Viruses from 105 cases of chickenpox and 144 of zoster were typed. Two alleles of R5, A and B, were found at prevalences of 89 and 6%, respectively. No difference in allele frequency between the zoster and chickenpox cases was found, and no change in the frequencies of these alleles was observed to occur over time. By contrast, a BglI restriction site (BglI+) was found with increasing frequency over time among cases of varicella (P < 0.005) and, to a lesser extent, cases of zoster. The BglI+ polymorphism was strongly associated (P < 0.0005) with zoster in subjects who had immigrated to the United Kingdom from countries with low adult immunity to varicella (LAIV). Sixty-three percent of the subjects with zoster who had emigrated from countries with LAIV carried the BglI+ virus, in contrast to 10% of adults who had grown up in countries with high adult immunity to varicella. The significance of these data, in view of the changing epidemiology of chickenpox, is discussed.

Full Text

The Full Text of this article is available as a PDF (125.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams S. G., Dohner D. E., Gelb L. D. Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus. J Med Virol. 1989 Sep;29(1):38–45. doi: 10.1002/jmv.1890290108. [DOI] [PubMed] [Google Scholar]
  2. Dohner D. E., Adams S. G., Gelb L. D. Recombination in tissue culture between varicella-zoster virus strains. J Med Virol. 1988 Mar;24(3):329–341. doi: 10.1002/jmv.1890240310. [DOI] [PubMed] [Google Scholar]
  3. Fairley C. K., Miller E. Varicella-zoster virus epidemiology--a changing scene? J Infect Dis. 1996 Nov;174 (Suppl 3):S314–S319. doi: 10.1093/infdis/174.supplement_3.s314. [DOI] [PubMed] [Google Scholar]
  4. Garnett G. P., Cox M. J., Bundy D. A., Didier J. M., St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect. 1993 Apr;110(2):361–372. doi: 10.1017/s0950268800068308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gelb L. D., Dohner D. E., Gershon A. A., Steinberg S. P., Waner J. L., Takahashi M., Dennehy P. H., Brown A. E. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J Infect Dis. 1987 Apr;155(4):633–640. doi: 10.1093/infdis/155.4.633. [DOI] [PubMed] [Google Scholar]
  6. Gray G. C., Palinkas L. A., Kelley P. W. Increasing incidence of varicella hospitalizations in United States Army and Navy personnel: are today's teenagers more susceptible? Should recruits be vaccinated? Pediatrics. 1990 Dec;86(6):867–873. [PubMed] [Google Scholar]
  7. Hawrami K., Harper D., Breuer J. Typing of varicella zoster virus by amplification of DNA polymorphisms. J Virol Methods. 1996 Apr 5;57(2):169–174. doi: 10.1016/0166-0934(95)01981-2. [DOI] [PubMed] [Google Scholar]
  8. Hondo R., Yogo Y. Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J Virol. 1988 Aug;62(8):2916–2921. doi: 10.1128/jvi.62.8.2916-2921.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hondo R., Yogo Y., Yoshida M., Fujima A., Itoh S. Distribution of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation. Jpn J Exp Med. 1989 Dec;59(6):233–237. [PubMed] [Google Scholar]
  10. LaRussa P., Lungu O., Hardy I., Gershon A., Steinberg S. P., Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992 Feb;66(2):1016–1020. doi: 10.1128/jvi.66.2.1016-1020.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shiraki K., Horiuchi K., Asano Y., Yamanishi K., Takahashi M. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact. J Med Virol. 1991 Feb;33(2):128–132. doi: 10.1002/jmv.1890330212. [DOI] [PubMed] [Google Scholar]
  12. Straus S. E., Hay J., Smith H., Owens J. Genome differences among varicella-zoster virus isolates. J Gen Virol. 1983 May;64(Pt 5):1031–1041. doi: 10.1099/0022-1317-64-5-1031. [DOI] [PubMed] [Google Scholar]
  13. Takada M., Suzutani T., Yoshida I., Matoba M., Azuma M. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J Clin Microbiol. 1995 Mar;33(3):658–660. doi: 10.1128/jcm.33.3.658-660.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES